Research map: Resistant depression, biomarkers, and comorbidity in clinical practice

Back to the article

Papers in this map

  1. NAD+ metabolism and its roles in cellular processes during ageing · Anthony J. Covarrubias · 2020 · 1629 citations · Cited by this paper
  2. Lumateperone monotherapy for major depressive episodes associated with bipolar disorder: efficacy and safety in a randomized placebo-controlled trial · 2025 · Related
  3. Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STAR*D Report · Maurizio Fava · 2008 · 942 citations · Cited by this paper
  4. Unspoken needs: an essential perspective in the treatment of schizophrenia · 2026 · Related
  5. Defining treatment‐resistant depression · Bradley Neil Gaynes · 2019 · 447 citations · Cited by this paper
  6. The identification, assessment and management of difficult-to-treat depression: An international consensus statement · Hamish McAllister-Williams · 2020 · 285 citations · Cited by this paper
  7. Common ground in Attention Deficit Hyperactivity Disorder (ADHD) and Borderline Personality Disorder (BPD)–review of recent findings · Swantje Matthies · 2014 · 111 citations · Cited by this paper
  8. Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial · George I. Papakostas · 2024 · 57 citations · Cited by this paper
  9. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials · James Craig Nelson · 2009 · 56 citations · Cited by this paper
  10. The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response? · Gianluca Borgiani · 2024 · 38 citations · Cited by this paper
  11. Addition of methylphenidate to intensive dialectical behaviour therapy for patients suffering from comorbid borderline personality disorder and ADHD: a naturalistic study · Paco Prada · 2015 · 37 citations · Cited by this paper
  12. Association of pharmacological treatments and real‐world outcomes in borderline personality disorder · Johannes Lieslehto · 2023 · 29 citations · Cited by this paper
  13. Circulating blood eNAMPT drives the circadian rhythms in locomotor activity and energy expenditure · Jae-Woo Park · 2023 · 24 citations · Cited by this paper
  14. Resistance to antidepressant treatment among patients with major depressive disorder: a nationwide study · Li-Chi Chen · 2024 · 14 citations · Cited by this paper
  15. Safety and tolerability of cariprazine for the adjunctive treatment of major depressive disorder: a pooled analysis of phase 2b/phase 3 clinical trials · Michael E. Thase · 2024 · 12 citations · Cited by this paper
  16. Metabolic syndrome and its relation to antipsychotic polypharmacy in schizophrenia, schizoaffective and bipolar disorders · Karim Abdel Aziz · 2024 · 9 citations · Cited by this paper
  17. Raising awareness for adult ADHD diagnosis: addressing diagnostic challenges, comorbidities, and the path to proper recognition · Camilla Elefante · 2025 · 4 citations · Cited by this paper
  18. Patient treatment preference as a predictor of clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and nonresponders with treatment-resistant depression (ASCERTAIN-TRD) · Stefania Chaikali · 2026 · 3 citations · Cited by this paper
  19. Underinvestigated aspects of depression treatment: comorbidity, quality-of-life, and novel adjuncts · Alessandro Serretti · 2025 · 1 citation · Cited by this paper
  20. Neurological features in psychiatric disorders: biomarkers, comorbidity, and clinical translation · Alessandro Serretti · 2025 · 1 citation · Cited by this paper
  21. Antidepressant treatment in complex clinical pictures · Alessandro Serretti · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)